Sudeep Pharma IPO subscribed 5 times on Day 02; NII portion sees strong demand; GMP signals 19% premium

Sudeep Pharma’s IPO, valued at ₹895 crore, has garnered healthy interest, with a subscription rate over 5 times. The retail portion was subscribed 5.02 times, while the NII portion saw 12 times subscription. Listing is expected on November 28.

Read Full